BACKGROUND: Several studies have assessed risk factors associated with herpes simplex virus-2 (HSV-2) prevalence in adults; however, few have focused on HSV-2 incidence, particularly in adolescents. The objective of this study was to determine HSV-2 prevalence and incidence and associated risk factors in a HIV-1-positive and at risk HIV-1-negative adolescent population. METHODS: Sera were tested for HSV-2 antibodies in 518 adolescents in the Reaching for Excellence in Adolescent Care and Health cohort at baseline and again at the final follow-up visit. Prevalence at baseline and incidence (per person years) of HSV-2 infection were calculated. Furthermore, among HIV-1-positive individuals, a subgroup analysis was performed to assess risk factors for HSV-2 infection. Conditional logistic regression was used to estimate odds ratios and P values for associations between CD4+ T-cell (CD4+) count, HIV-1 viral load (VL), and HSV-2 acquisition, adjusting for antiretroviral therapy use, other sexually transmitted infections, gender, race, and number of sexual partners. RESULTS: At baseline, 179 (35%) subjects were HSV-2 positive, with an additional 47 (16%) new cases being identified during a median follow-up time of 1.95 years and an incidence rate of 7.35 cases per 100 person years. Several risk factors were associated with HSV-2 prevalence (being female, non-Hispanic, uncertainty of sexual preference, and HIV-1 positive) and incidence (using drugs, alcohol, and number of new sexual partners). Among HIV-1 positives, an increase in CD4+ count by 50 cell/mm(3) (odds ratio, 1.17; 95% CI, 1.04-1.31, P = 0.008) was associated with HSV-2 acquisition. CONCLUSIONS: The high prevalence and incidence of HSV-2 infection among adolescents, compared with the general population at this age group suggests a critical need for screening and preventive programs among this targeted group.
BACKGROUND: Several studies have assessed risk factors associated with herpes simplex virus-2 (HSV-2) prevalence in adults; however, few have focused on HSV-2 incidence, particularly in adolescents. The objective of this study was to determine HSV-2 prevalence and incidence and associated risk factors in a HIV-1-positive and at risk HIV-1-negative adolescent population. METHODS: Sera were tested for HSV-2 antibodies in 518 adolescents in the Reaching for Excellence in Adolescent Care and Health cohort at baseline and again at the final follow-up visit. Prevalence at baseline and incidence (per person years) of HSV-2 infection were calculated. Furthermore, among HIV-1-positive individuals, a subgroup analysis was performed to assess risk factors for HSV-2 infection. Conditional logistic regression was used to estimate odds ratios and P values for associations between CD4+ T-cell (CD4+) count, HIV-1 viral load (VL), and HSV-2 acquisition, adjusting for antiretroviral therapy use, other sexually transmitted infections, gender, race, and number of sexual partners. RESULTS: At baseline, 179 (35%) subjects were HSV-2 positive, with an additional 47 (16%) new cases being identified during a median follow-up time of 1.95 years and an incidence rate of 7.35 cases per 100 person years. Several risk factors were associated with HSV-2 prevalence (being female, non-Hispanic, uncertainty of sexual preference, and HIV-1 positive) and incidence (using drugs, alcohol, and number of new sexual partners). Among HIV-1 positives, an increase in CD4+ count by 50 cell/mm(3) (odds ratio, 1.17; 95% CI, 1.04-1.31, P = 0.008) was associated with HSV-2 acquisition. CONCLUSIONS: The high prevalence and incidence of HSV-2 infection among adolescents, compared with the general population at this age group suggests a critical need for screening and preventive programs among this targeted group.
Authors: Anna Wald; Andria G M Langenberg; Elizabeth Krantz; John M Douglas; H Hunter Handsfield; Richard P DiCarlo; Adaora A Adimora; Allen E Izu; Rhoda Ashley Morrow; Lawrence Corey Journal: Ann Intern Med Date: 2005-11-15 Impact factor: 25.391
Authors: Fujie Xu; Maya R Sternberg; Benny J Kottiri; Geraldine M McQuillan; Francis K Lee; Andre J Nahmias; Stuart M Berman; Lauri E Markowitz Journal: JAMA Date: 2006-08-23 Impact factor: 56.272
Authors: María del Mar Pujades Rodríguez; Angela Obasi; Frank Mosha; Jim Todd; David Brown; John Changalucha; David Mabey; David Ross; Heiner Grosskurth; Richard Hayes Journal: AIDS Date: 2002-02-15 Impact factor: 4.177
Authors: Wan Beom Park; Hee-Chang Jang; Sung-Han Kim; Hong Bin Kim; Nam Joong Kim; Myoung-Don Oh; Kang Won Choe Journal: Sex Transm Dis Date: 2008-03 Impact factor: 2.830
Authors: Maria F Gallo; Lee Warner; Maurizio Macaluso; Katherine M Stone; Ilene Brill; Michael E Fleenor; Edward W Hook; Harland D Austin; Francis K Lee; André J Nahmias Journal: Sex Transm Dis Date: 2008-07 Impact factor: 2.830
Authors: Leigh Anne Shafer; Rebecca N Nsubuga; Richard White; Billy N Mayanja; Ruth Chapman; Katie O'brien; Lieve Van der Paal; Heiner Grosskurth; Dermot Maher Journal: AIDS Date: 2011-03-13 Impact factor: 4.177
Authors: J Daniel Kelly; Jennifer Cohen; Barbara Grimes; Susan S Philip; Sheri D Weiser; Elise D Riley Journal: J Womens Health (Larchmt) Date: 2016-05-31 Impact factor: 2.681
Authors: Sarah Samandary; Hédia Kridane-Miledi; Jacqueline S Sandoval; Zareen Choudhury; Francina Langa-Vives; Doran Spencer; Aziz A Chentoufi; François A Lemonnier; Lbachir BenMohamed Journal: Hum Immunol Date: 2014-05-04 Impact factor: 2.850
Authors: Tanya L Kowalczyk Mullins; Su X Li; James Bethel; Maureen M Goodenow; Stephanie Hudey; John W Sleasman Journal: J Clin Virol Date: 2018-02-07 Impact factor: 3.168
Authors: David Champredon; Steven E Bellan; Wim Delva; Spencer Hunt; Chyun-Fung Shi; Marek Smieja; Jonathan Dushoff Journal: BMC Infect Dis Date: 2015-06-30 Impact factor: 3.090
Authors: Eduardo I Tognarelli; Tomás F Palomino; Nicolás Corrales; Susan M Bueno; Alexis M Kalergis; Pablo A González Journal: Front Cell Infect Microbiol Date: 2019-04-30 Impact factor: 5.293
Authors: Heather J Goux; Balakrishnan Raja; Katerina Kourentzi; João R C Trabuco; Binh V Vu; Andrew S Paterson; Alexander Kirkpatrick; Blane Townsend; Miles Lee; Van Thi Thanh Truong; Claudia Pedroza; Richard C Willson Journal: PLoS One Date: 2019-12-10 Impact factor: 3.752